Market closed
Tyra Biosciences/$TYRA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Tyra Biosciences
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.
Ticker
$TYRA
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
60
ISIN
US90240B1061
Website
Tyra Biosciences Metrics
BasicAdvanced
$535M
-
-$1.51
1.09
-
Price and volume
Market cap
$535M
Beta
1.09
52-week high
$27.66
52-week low
$6.42
Average daily volume
353K
Financial strength
Current ratio
23.809
Quick ratio
23.533
Long term debt to equity
1.693
Total debt to equity
1.813
Management effectiveness
Return on assets (TTM)
-22.09%
Return on equity (TTM)
-31.60%
Valuation
Price to book
1.49
Price to tangible book (TTM)
1.49
Price to free cash flow (TTM)
-8.18
Growth
Earnings per share change (TTM)
-6.64%
3-year earnings per share growth (CAGR)
-7.47%
What the Analysts think about Tyra Biosciences
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Tyra Biosciences stock.
Tyra Biosciences Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Tyra Biosciences Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Tyra Biosciences stock?
Tyra Biosciences (TYRA) has a market cap of $535M as of May 10, 2025.
What is the P/E ratio for Tyra Biosciences stock?
The price to earnings (P/E) ratio for Tyra Biosciences (TYRA) stock is 0 as of May 10, 2025.
Does Tyra Biosciences stock pay dividends?
No, Tyra Biosciences (TYRA) stock does not pay dividends to its shareholders as of May 10, 2025.
When is the next Tyra Biosciences dividend payment date?
Tyra Biosciences (TYRA) stock does not pay dividends to its shareholders.
What is the beta indicator for Tyra Biosciences?
Tyra Biosciences (TYRA) has a beta rating of 1.09. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.